| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=1uM, 3-Dimethylcarbamoylmethyl-5-fluoro-1-naphthalen-1-ylmethyl-1H-indole-2-carboxylic acid, Known Chymase inhibitor targeting CMA1 (Novartis, 23582811) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/23582811 |
| Similar Terms | |
| Downloads & Tools |
6 genes differentially expressed following the AC-40-PV46_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| RHOG | ras homolog family member G | 0.625023 |
| PHPT1 | phosphohistidine phosphatase 1 | 0.619823 |
| LBHD1 | LBH domain containing 1 | 0.396567 |
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase | 0.356345 |
| C19ORF33 | chromosome 19 open reading frame 33 | 0.316924 |
| PGLYRP2 | peptidoglycan recognition protein 2 | 0.316924 |